NYSE: STZ

CONSTELLATION BRANDS, INC.

CIK 0000016918 · SIC 2080 · Beverages

Large Revenue $9.1B Assets $22.1B as of Sep 27, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (IPW 10-K) is open in full — no account needed.

8-K Filed Sep 18, 2026 · Period ending Sep 18, 2026

Constellation Brands enters $300M delayed draw term loan credit agreement

5 material changes detected. Sign up free to read the summary.

8-K Filed Sep 8, 2026 · Period ending Sep 8, 2026

Summary not yet generated.

Partner

Trade STZ commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jul 24, 2026 · Period ending Jul 22, 2026 Red flag

Constellation Brands holds annual meeting; 8-K filing appears incomplete on Item 5.02

5 material changes detected. Sign up free to read the summary.

10-Q Filed Jul 1, 2026 · Period ending May 31, 2026 Red flag

revenue $2.43B, net income $653.8M. Beer volume rebounds 26.7% as aluminum tariffs lifted; Wine stabilizes post-divestiture

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 30, 2026 · Period ending Jun 30, 2026

Constellation Brands reports Q1 FY2027 EPS up 31% to $3.79, raises guidance, returns $400M+

5 material changes detected. Sign up free to read the summary.

8-K Filed May 21, 2026 · Period ending May 20, 2026

Constellation Brands adds McDonald's global CMO Morgan Flatley to board

3 material changes detected. Sign up free to read the summary.

8-K Filed May 6, 2026 · Period ending May 6, 2026

Summary not yet generated.

8-K Filed May 5, 2026 · Period ending May 4, 2026

Summary not yet generated.

424B3 Filed May 4, 2026

Summary not yet generated.

10-K Filed Apr 22, 2026 · Period ending Feb 28, 2026

Summary not yet generated.

10-Q Filed Jan 8, 2026 · Period ending Nov 30, 2025

Summary not yet generated.

424B3 Filed Oct 15, 2025

Summary not yet generated.

10-Q Filed Jul 2, 2025 · Period ending May 31, 2025

Summary not yet generated.

424B3 Filed Apr 29, 2025

Summary not yet generated.

10-K Filed Apr 23, 2025 · Period ending Feb 28, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 1, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

(in millions, except per share data)

Description Three months ended May 31, 2026 Three months ended May 31, 2025
NET INCOME (LOSS) ATTRIBUTABLE TO CBI
Sales 2,590.4 2,677.5
Excise taxes (157.7) (162.5)
Net sales 2,432.7 2,515.0
Cost of product sold (1,112.1) (1,248.4)
Gross profit 1,320.6 1,266.6
Selling, general, and administrative expenses (457.0) (500.7)
Asset impairment and related expenses (18.3) (52.1)
Operating income (loss) 845.3 713.8
Income (loss) from unconsolidated investments 0.5 (3.5)
Interest expense, net (85.8) (98.9)
Income (loss) before income taxes 760.0 611.4
(Provision for) benefit from income taxes (88.1) (87.6)
Net income (loss) 671.9 523.8
Net (income) loss attributable to noncontrolling interests (18.1) (7.7)
Net income (loss) attributable to CBI 653.8 516.1
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI
Comprehensive income (loss) 583.1 888.1
Comprehensive (income) loss attributable to noncontrolling interests (14.7) (21.3)
Comprehensive income (loss) attributable to CBI 568.4 866.8
CLASS A STOCK
Net income (loss) per common share attributable to CBI basic 3.80 2.90
Net income (loss) per common share attributable to CBI diluted 3.79 2.90
Weighted average common shares outstanding basic 172.186 177.801
Weighted average common shares outstanding diluted 172.407 177.991
Cash dividends declared per common share 1.03 1.02

Consolidated Balance Sheets (Unaudited)

(in millions, except share and per share data)

Description May 31, 2026 February 28, 2026
ASSETS
Current assets:
Cash and cash equivalents 96.6 102.4
Accounts receivable 726.7 658.2
Inventories 1,452.6 1,433.9
Prepaid expenses and other 765.1 711.8
Total current assets 3,041.0 2,906.3
Property, plant, and equipment, net of accumulated depreciation of $3,140.8 and $3,095.1, respectively 8,510.2 8,520.9
Goodwill 5,248.9 5,233.9
Intangible assets 2,536.8 2,533.0
Deferred income taxes 1,459.2 1,370.3
Other assets 1,312.6 1,336.1
Total assets 22,108.7 21,900.5
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings 336.3 272.0
Current maturities of long-term debt 1,102.6 603.6
Accounts payable 1,000.1 960.2
Other accrued expenses and liabilities 890.0 854.0
Total current liabilities 3,329.0 2,689.8
Long-term debt, less current maturities 9,094.9 9,692.9
Deferred income taxes and other liabilities 1,135.0 1,130.9
Total liabilities 13,558.9 13,513.6
Commitments and contingencies
CBI stockholders’ equity:
Class A Stock, $0.01 par value Authorized, 322,000,000 shares; Issued, 212,699,542 shares and 212,699,542 shares, respectively 2.1 2.1
Additional paid-in capital 2,168.7 2,185.7
Retained earnings 14,050.3 13,574.4
Accumulated other comprehensive income (loss) 337.8 423.2
Class A Stock in treasury, at cost, 41,232,646 shares and 39,927,096 shares, respectively (8,303.3) (8,103.0)
Total CBI stockholders’ equity 8,255.6 8,082.4
Noncontrolling interests 294.2 304.5
Total stockholders’ equity 8,549.8 8,386.9
Total liabilities and stockholders’ equity 22,108.7 21,900.5

Consolidated Statements of Cash Flows (Unaudited)

(in millions)

Description Three months ended May 31, 2026 Three months ended May 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) 671.9 523.8
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred tax provision (benefit) (78.4) 34.0
Depreciation 97.6 105.2
Stock-based compensation 15.0 10.4
Noncash lease expense 33.5 31.0
Asset impairment and related expenses 18.3 52.1
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable (66.4) (73.9)
Inventories (34.4) (20.8)
Prepaid expenses and other current assets (23.8) (25.8)
Accounts payable 48.0 36.7
Other accrued expenses and liabilities (7.2) (92.3)
Other (12.3) 56.8
Total adjustments (10.1) 113.4
Net cash provided by (used in) operating activities 661.8 637.2
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment (177.2) (192.8)
Purchase of business, net of cash acquired (15.3) —
Other investing activities (0.7) (3.3)
Net cash provided by (used in) investing activities (193.2) (196.1)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt 499.7 499.1
Principal payments of long-term debt (601.1) (1.0)
Net proceeds from (repayments of) short-term borrowings 64.4 (429.2)
Dividends paid (178.7) (182.2)
Purchases of treasury stock (223.8) (306.1)
Proceeds from shares issued under equity compensation plans 3.9 5.3
Payments of minimum tax withholdings on stock-based payment awards (10.2) (9.4)
Payments of debt issuance, debt extinguishment, and other financing costs (2.9) (5.2)
Distributions to noncontrolling interests (25.0) (7.5)
Payment of contingent consideration (0.3) (1.4)
Net cash provided by (used in) financing activities (474.0) (437.6)
Effect of exchange rate changes on cash and cash equivalents (0.4) 2.3
Net increase (decrease) in cash and cash equivalents (5.8) 5.8
Cash and cash equivalents, beginning of period 102.4 68.1
Cash and cash equivalents, end of period 96.6 73.9
SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES
Additions to property, plant, and equipment 103.1 120.3

Amounts as printed on the EDGAR/iXBRL face — (in millions, except per share data); (in millions, except share and per share data); (in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing